These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6122288)

  • 61. [Pharmacodynamics of carteolol].
    Odenthal KP
    Arzneimittelforschung; 1983; 33(2a):281-5. PubMed ID: 6132609
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Platelet calcium and quenched-flow aggregation kinetics in essential hypertension.
    Taylor MA; Ayers CR; Gear AR
    Hypertension; 1989 Jun; 13(6 Pt 1):558-66. PubMed ID: 2525522
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) release by adenosine diphosphate (ADP) contact with native whole blood.
    Pengo V; Boschello M; Prandoni P; Schivazappa L; Girolami A
    Thromb Res; 1985 Sep; 39(5):645-50. PubMed ID: 2417360
    [No Abstract]   [Full Text] [Related]  

  • 64. Dose-dependent effects of verapamil and nifedipine on in vivo platelet function in normal volunteers.
    Winther K; Jespersen CM; Rydberg B; Thamsborg G; Hedner T
    Eur J Clin Pharmacol; 1990; 39(3):291-3. PubMed ID: 2147908
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synergism between collagen-adenosine diphosphate and collagen-epinephrine in platelets' aggregation: different dose response relationships.
    Razi MS; Hameed W; Habib SS; Aslam M; Ashraf R
    J Pak Med Assoc; 2009 Jun; 59(6):368-71. PubMed ID: 19534370
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inter-relationships between platelet response to adenosine diphosphate, blood coagulation and serum lipids in patients with peripheral occlusive atherosclerosis.
    Cotton RC; Bloor K; Archibald G
    Atherosclerosis; 1972; 16(3):337-48. PubMed ID: 4657743
    [No Abstract]   [Full Text] [Related]  

  • 67. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of donor characteristics and platelet in vitro time and temperature on platelet aggregometry.
    Silver WP; Keller MP; Teel R; Silver D
    J Vasc Surg; 1993 Apr; 17(4):726-33. PubMed ID: 8464092
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
    Kerry R; Scrutton MC; Wallis RB
    Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of beta-blocking or alpha.beta-blocking agents upon circadian cardiovascular rhythm of healthy male subjects.
    Otsuka K; Watanabe H; Cornelissen G; Halberg E; Halberg F
    Prog Clin Biol Res; 1990; 341A():297-304. PubMed ID: 1699233
    [No Abstract]   [Full Text] [Related]  

  • 71. Platelet function in patients receiving enprostil.
    Bunce I; Ward M; Solomon E; Cowen A
    Am J Med; 1986 Aug; 81(2A):85-8. PubMed ID: 2944380
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of S-596 and carteolol, new beta-adrenergic blockers, and flurbiprofen on the human eye: a fluorophotometric study.
    Araie M; Takase M
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):259-62. PubMed ID: 2579877
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol.
    Floreani M; Froldi G; Quintieri L; Varani K; Borea PA; Dorigo MT; Dorigo P
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1386-95. PubMed ID: 16160085
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of an automated light transmission aggregometry.
    Ling LQ; Liao J; Niu Q; Wang X; Jia J; Zuo CH; Jiang H; Zhou J
    Platelets; 2017 Nov; 28(7):712-719. PubMed ID: 28150526
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Kinetics of the beta-thromboglobulin release from alpha-granules of blood platelets activated by ADP.
    Walkowiak B; Cierniewski CS
    Thromb Res; 1987 Jun; 46(5):727-36. PubMed ID: 2957817
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
    Sudo T; Ito H; Ozeki Y; Kimura Y
    Br J Pharmacol; 2001 Aug; 133(8):1396-404. PubMed ID: 11498527
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Effects of pilocarpine and carteolol, a new beta-adrenergic blocking agent on human aqueous humor dynamics (author's transl)].
    Araie M; Takase M
    Nippon Ganka Gakkai Zasshi; 1980 Dec; 84(12):2085-91. PubMed ID: 7246372
    [No Abstract]   [Full Text] [Related]  

  • 78. Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats.
    Igawa T; Ikezono K; Watanabe K; Kimura Y
    Eur J Pharmacol; 1984 Sep; 104(1-2):93-9. PubMed ID: 6238834
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of beta-adrenoceptor blockade on exercise-induced plasma catecholamine concentration-heart rate response relationship.
    Ohnishi A; Minegishi A; Ishizaki T
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):667-74. PubMed ID: 2450237
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.